{"version":"1.0","type":"link","title":"Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis.","author_name":"Xiang L 외","author_url":"https://prs-insight.online/author/Xiang%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/109080","thumbnail_width":1200,"thumbnail_height":630}